Ari Zweiman
@683 Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$1.315BTotal holdings139
Assets growth rate-0.62%Assets growth rate (2-Q avg)-1.9%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in 683 Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 139 positions.
Assets under management
The assets under management (AUM) of 683 Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.315B in assets, with a quarterly growth rate of -0.62% and a 2-quarter average growth rate of -1.9%. The portfolio is managed by Ari Zweiman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CDLXCardlytics Inc
| 0.55% | $7.12M 2.225M shares@ $3.2 avg price | Increased 5.96% |
AMLXAmylyx Pharmaceuticals Inc
| 0.5% | $6.48M 2M shares@ $3.24 avg price | Increased 33.17% |
AGROAdecoagro S A
| 0.48% | $6.255M 565,000 shares@ $11.07 avg price | Increased 13% |
GOSSGossamer Bio Inc
| 0.44% | $5.721M 5.8M shares@ $0.99 avg price | Increased 0.87% |
IRS.⤦Irsa Inversiones Y Rep S A
| 0.36% | $4.607M 4.75M shares@ $0.97 avg price | Increased 1.69% |
SAGESage Therapeutics Inc
| 0.33% | $4.332M 600,000 shares@ $7.22 avg price | Increased 20% |
ABEOAbeona Therapeutics Inc
| 0.33% | $4.266M 675,000 shares@ $6.32 avg price | Increased 12.5% |
VIGLVigil Neuroscience Inc
| 0.32% | $4.147M 1.22M shares@ $3.4 avg price | Increased 10.88% |
LPTXLeap Therapeutics Inc
| 0.27% | $3.548M 1.381M shares@ $2.58 avg price | Increased 6.2% |
HDSNHudson Technologies Inc
| 0.22% | $2.8M 335,790 shares@ $8.34 avg price | Increased 34.02% |